Pulmovant – Talk Bio

Actionable Insights Powered by AI

Roivant Sciences Acquires Experimental Pulmonary Hypertension Drug Mosliciguat from Bayer

Roivant Sciences, Pulmovant, Bayer, Mosliciguat, Pulmonary Hypertension, PH-ILD, Interstitial Lung Disease